Clinical Study of 18F-FAPI-RGD in Breast Tumors
NCT05976620 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2024-07-15
Summary
The goal of this observational study is to learn about the value of 18F-FAPI-RGD PET/CT imaging in Breast Tumors. Participants will undergo clinical evaluation and 18F-FAPI-RGD PET/CT examination.
Conditions
- Breast Tumors
Sponsors & Collaborators
-
Sichuan Provincial People's Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-20
- Primary Completion
- 2023-12-15
- Completion
- 2024-02-20
Countries
- China
Study Locations
More Related Trials
-
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
NCT06126705 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
NCT05749302 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Tracer Targeting FAP PET Imaging in Patients
NCT05691894 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
18F-FAPI and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05485792 ·Status: UNKNOWN ·Phase: NA
-
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
NCT06937112 ·Status: RECRUITING
-
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324 ·Status: UNKNOWN ·Phase: NA
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer
NCT03768479 ·Status: UNKNOWN ·Phase: NA
-
Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection
NCT06206642 ·Status: COMPLETED ·Phase: NA
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
Characterizing Breast Cancer With 18F-FES PET/CT
NCT05613270 ·Status: UNKNOWN ·Phase: NA
-
Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer
NCT06797622 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma
NCT06277206 ·Status: COMPLETED
-
Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy
NCT05828238 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Rationale and Trial Design of PFB-03 Study: Diagnostic Performance and Clinical Application of 18F-FAPI-PET/CT for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients After Neoadjuvant Therapy
NCT07012707 ·Status: NOT_YET_RECRUITING
-
18F-FAPIBiotin PET/CT: Dosimetry and Biodistribution Study
NCT06734572 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application
NCT06270394 ·Status: COMPLETED ·Phase: NA
-
18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
NCT06335069 ·Status: RECRUITING ·Phase: PHASE2
-
FDG PET-CT in Advanced Breast Cancer
NCT07173868 ·Status: RECRUITING
-
Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET
NCT07285993 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
18F-FSPG PET/CT Imaging in Patients With Cancers
NCT03144622 ·Status: UNKNOWN
-
Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer
NCT01627704 ·Status: COMPLETED ·Phase: NA
-
To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT
NCT06205888 ·Status: NOT_YET_RECRUITING
-
18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain
NCT01621906 ·Status: COMPLETED ·Phase: NA